Ingen Technologies Inc
OTC:IGNT
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Ingen Technologies Inc
OTC:IGNT
|
89.6 USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
190.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
181.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
140.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
139.4B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.6B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.1B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.2B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
54.1B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.1B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Ingen Technologies Inc
Glance View
Ingen Technologies, Inc. engages in the manufacture of respiratory medical devices. The company is headquartered in Riverside, California. The company went IPO on 2001-07-11. The firm through its subsidiary, Ingen Technologies, Inc., is engaged in medical device manufacturing. The firm manufactures medical equipment for patients suffering with chronic obstructive pulmonary disease (COPD) and requiring oxygen therapy through home healthcare, hospitals, military and government-based medical facilities. The firm manufactures oxygen flow meters and nasal cannulas under Oxyview and Smart Nasal Cannula names. The firm offers both a reusable Oxyview and a disposable Smart Nasal Cannula with Oxyview attached to a nasal cannula. Oxyview is a pneumatic oxygen in-line flow meter. The Smart Nasal Cannula with Oxyview is a disposable nasal cannula that includes the Oxyview assembled and in-line. Oxyview is manufactured in two models: model 206A and model 203A. The Smart Nasal Cannula is available in six models: models 203NCA, 206NCA, 203NCP, 206NCP, 203NCI and 206NCI.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, Ingen Technologies Inc’s Gross Margin has increased from 50% to 81.5%. During this period, it reached a low of 40% on Feb 28, 2011 and a high of 100% on Aug 31, 2012.